Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-ras gene.
C Sevignani, … , R V Iozzo, B Calabretta
C Sevignani, … , R V Iozzo, B Calabretta
Published April 15, 1998
Citation Information: J Clin Invest. 1998;101(8):1572-1580. https://doi.org/10.1172/JCI919.
View: Text | PDF
Research Article Article has an altmetric score of 3

Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-ras gene.

  • Text
  • PDF
Abstract

Distinct genetic abnormalities (loss-of-function mutations of APC and p53 and oncogenic activation of Ki-ras) are associated with specific stages of the sporadic, most common types of colorectal tumors. However, the inability to maintain primary colon epithelial cells in culture has hindered the analysis of the pathogenetic role of these abnormalities in colorectal tumorigenesis. We have now established primary cultures of epithelial cells from the colon crypts of p53-deficient mice; these cells are nontumorigenic as indicated by their failure to form colonies in soft agar and to grow as tumors in immunodeficient SCID mice and in immunocompetent syngeneic hosts. Upon ectopic expression of an activated Ki-ras gene, p53-deficient colon epithelial cells form colonies in soft agar and highly invasive subcutaneous tumors in both immunodeficient and immunocompetent mice. Ectopic expression of wild-type p53, but not of a DNA-binding-deficient mutant, markedly suppressed the colony-forming ability of the Ki-ras-transformed p53-deficient epithelial cells. Together, these findings establish a functional synergism in colorectal tumorigenesis dependent on the effects of an oncogenic Ki-ras in a p53-deficient background. This model of tumorigenic conversion of colon epithelial cells might be useful to identify genetic changes associated with disease progression and to evaluate the therapeutic response to conventional and novel anticancer drugs.

Authors

C Sevignani, P Wlodarski, J Kirillova, W E Mercer, K G Danielson, R V Iozzo, B Calabretta

×

Total citations by year

Year: 2020 2019 2015 2012 2011 2010 2009 2007 2006 2005 2004 2003 2002 2001 2000 1999 Total
Citations: 1 1 1 1 1 2 2 1 3 2 2 2 2 3 2 2 28
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (28)

Title and authors Publication Year
Regulation of immune cell metabolism by cancer cell oncogenic mutations
A Madi, G Cui
International Journal of Cancer 2020
Kolorektal kanserli hastalarda tümör dokusunda mikrosatellit instabilite taranması ve klinik üzerine etkinliği
S Yaraş
2019
Agonists of the TRAIL Death Receptor DR5 Sensitize Intestinal Stem Cells to Chemotherapy-Induced Cell Death and Trigger Gastrointestinal Toxicity
NK Finnberg, P Gokare, A Navaraj, KA Kuhs, G Cerniglia, H Yagita, K Takeda, N Motoyama, WS El-Deiry
Cancer research 2015
Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis
WK Wu, XJ Wang, AS Cheng, MX Luo, SS Ng, KF To, FK Chan, CH Cho, JJ Sung, J Yu
Critical Reviews in Oncology/Hematology 2012
Tumor suppressor protein kinase Chk2 is a mediator of anoikis of intestinal epithelial cells
BH Yoo, A Berezkin, Y Wang, A Zagryazhskaya, KV Rosen
International Journal of Cancer 2011
p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal
Z Zhao, J Zuber, E Diaz-Flores, L Lintault, SC Kogan, K Shannon, SW Lowe
Genes & development 2010
The Myc–miR-17∼92 Axis Blunts TGFβ Signaling and Production of Multiple TGFβ-Dependent Antiangiogenic Factors
M Dews, JL Fox, S Hultine, P Sundaram, W Wang, YY Liu, E Furth, GH Enders, W El-Deiry, JM Schelter, MA Cleary, A Thomas-Tikhonenko
Cancer research 2010
Rejection Reversibly Alters Enteroendocrine Cell Renewal in the Transplanted Small Intestine
TM Fishbein, G Novitskiy, DM Lough, C Matsumoto, SS Kaufman, K Shetty, M Zasloff
American Journal of Transplantation 2009
Cancer Genome and Tumor Microenvironment
A Thomas-Tikhonenko
2009
Functional Analysis of an Established Mouse Vascular Endothelial Cell Line
T Nishiyama, K Mishima, F Ide, K Yamada, K Obara, A Sato, N Hitosugi, H Inoue, K Tsubota, I Saito
Journal of Vascular Research 2007
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster
M Dews, A Homayouni, D Yu, D Murphy, C Sevignani, E Wentzel, EE Furth, WM Lee, GH Enders, JT Mendell, A Thomas-Tikhonenko
Nature Genetics 2006
Biological and oncogenic properties of p53-deficient salivary gland epithelial cells with particular emphasis on stromal-epithelial interactions in tumorigenesis
K Obara, F Ide, K Mishima, H Inoue, H Yamada, Y Hayashi, I Saito
Pathobiology 2006
Nutritional Oncology
D Heber
Nutritional Oncology 2006
Susceptibility of Heterozygous and Nullizygous p53 Knockout Mice to Chemical Carcinogens: Tissue Dependence and Role of p53 Gene Mutations
T Tsukamoto, A Hirata, M Tatematsu
Journal of Toxicologic Pathology 2005
A transient increase in the activity of Src-family kinases induced by cell detachment delays anoikis of intestinal epithelial cells
MA Loza-Coll, S Perera, W Shi, J Filmus
Oncogene 2005
Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo
A Thomas-Tikhonenko, I Viard-Leveugle, M Dews, P Wehrli, C Sevignani, D Yu, S Ricci, W el-Deiry, B Aronow, G Kaya, JH Saurat, LE French
Cancer research 2004
Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity
MS Ricci, Z Jin, M Dews, D Yu, A Thomas-Tikhonenko, DT Dicker, WS El-Deiry
Molecular and cellular biology 2004
Infection and cancer: the common vein
A Thomas-Tikhonenko, CA Hunter
Cytokine & Growth Factor Reviews 2003
High susceptibility of nullizygous p53 knockout mice to colorectal tumor induction by 1,2-dimethylhydrazine
H Sakai, T Tsukamoto, M Yamamoto, N Shirai, T Iidaka, A Hirata, T Yanai, T Masegi, LA Donehower, M Tatematsu
Journal of Cancer Research and Clinical Oncology 2003
In vitro models for the identification and characterization of tumor-promoting and protective factors for colon carcinogenesis
B Marian
Food and Chemical Toxicology 2002
Cell Detachment Triggers p38 Mitogen-activated Protein Kinase-dependent Overexpression of Fas Ligand: A NOVEL MECHANISM OF ANOIKIS OF INTESTINAL EPITHELIAL CELLS
K Rosen, W Shi, B Calabretta, J Filmus
The Journal of biological chemistry 2002
Nuclear Factor-κB Regulates Cyclooxygenase-2 Expression and Cell Proliferation in Human Gastric Cancer Cells
JW Lim, H Kim, KH Kim
Laboratory Investigation 2001
Anchorage-Independent Growth of p53 -Knockout Dermal Fibroblasts is Reversed by Wild-Type p53
JA Bush, G Li
Journal of Cutaneous Medicine & Surgery 2001
Cutting Edge: Systemic Inhibition of Angiogenesis Underlies Resistance to Tumors During Acute Toxoplasmosis
CA Hunter, D Yu, M Gee, CV Ngo, C Sevignani, M Goldschmidt, TV Golovkina, S Evans, WF Lee, A Thomas-Tikhonenko
Journal of immunology (Baltimore, Md. : 1950) 2001
Molecular interactions in the Vogelstein model of colorectal carcinoma
JW Arends
The Journal of Pathology 2000
Overexpression of Bamacan/SMC3 Causes Transformation
G Ghiselli, RV Iozzo
The Journal of biological chemistry 2000
Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis
RV Iozzo, F Chakrani, D Perrotti, DJ McQuillan, T Skorski, B Calabretta, I Eichstetter
Proceedings of the National Academy of Sciences 1999
Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts
F Kullmann, M Judex, I Neudecker, S Lechner, HP Jsten, DR Green, D Wessinghage, GS Firestein, S Gay, J Schlmerich, U Mller-Ladner
Arthritis & Rheumatism 1999

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 6 patents
20 readers on Mendeley
See more details